Interpace Biosciences, Inc. (IDXG)
OTCMKTS · Delayed Price · Currency is USD
0.7800
-0.0200 (-2.50%)
Jul 9, 2025, 11:48 AM EDT

Interpace Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
412543113
Upgrade
Market Cap Growth
-36.54%152.98%5.76%-85.77%145.72%-33.55%
Upgrade
Enterprise Value
76360588753
Upgrade
Last Close Price
0.802.701.081.047.473.14
Upgrade
PE Ratio
2.371.902.40---
Upgrade
PS Ratio
0.070.250.120.140.940.39
Upgrade
PB Ratio
-6.08-5.35-0.52-0.277.570.73
Upgrade
P/FCF Ratio
0.703.151.41---
Upgrade
P/OCF Ratio
0.602.561.24---
Upgrade
EV/Sales Ratio
0.141.351.491.822.621.63
Upgrade
EV/EBITDA Ratio
0.677.5511.97---
Upgrade
EV/EBIT Ratio
0.757.8315.07---
Upgrade
EV/FCF Ratio
1.2916.8418.00---
Upgrade
Debt / Equity Ratio
-7.28-2.64-1.24-0.972.600.27
Upgrade
Debt / EBITDA Ratio
0.430.641.93-34.59-
Upgrade
Debt / FCF Ratio
0.831.553.37---
Upgrade
Asset Turnover
3.623.362.751.170.790.67
Upgrade
Inventory Turnover
14.6313.9512.2213.289.9511.18
Upgrade
Quick Ratio
1.150.940.750.690.470.59
Upgrade
Current Ratio
1.341.110.910.850.780.78
Upgrade
Return on Equity (ROE)
-----65.25%-133.86%
Upgrade
Return on Assets (ROA)
41.40%36.32%17.03%-8.82%-8.57%-30.83%
Upgrade
Return on Capital (ROIC)
-173.90%284.05%-33.34%-19.45%-58.78%
Upgrade
Return on Capital Employed (ROCE)
151.70%194.10%235.90%---
Upgrade
Earnings Yield
202.83%56.45%41.64%-494.86%-47.92%-208.43%
Upgrade
FCF Yield
143.88%31.75%70.72%-180.61%-29.10%-122.56%
Upgrade
Buyback Yield / Dilution
-391.99%-260.54%-2.97%-2.49%-2.63%-7.56%
Upgrade
Updated Nov 8, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.